Assessment of Risk Factors of Polycystic Ovarian Syndrome Among Women: An Online Based Survey

Pharmaceutical Science-Pharmacy practice

Authors

  • S. M. G. Ishrar Department of Pharmacy Practice, Raghavendra Institute of Pharmaceutical Education and Research (RIPER), KR Palli Cross, Chiyyedu Post, Anantapur – 515721, Andhra Pradesh, India
  • Goruntla Narayana Department of Pharmacy Practice, Raghavendra Institute of Pharmaceutical Education and Research (RIPER), KR Palli Cross, Chiyyedu Post, Anantapur – 515721, Andhra Pradesh, India
  • Asma Aneesa.K. S Department of Pharmacy Practice, Raghavendra Institute of Pharmaceutical Education and Research (RIPER), KR Palli Cross, Chiyyedu Post, Anantapur – 515721, Andhra Pradesh, India
  • Chennampalli Priya Department of Pharmacy Practice, Raghavendra Institute of Pharmaceutical Education and Research (RIPER), KR Palli Cross, Chiyyedu Post, Anantapur – 515721, Andhra Pradesh, India
  • Roddam Swetha Department of Pharmacy Practice, Raghavendra Institute of Pharmaceutical Education and Research (RIPER), KR Palli Cross, Chiyyedu Post, Anantapur – 515721, Andhra Pradesh, India

DOI:

https://doi.org/10.22376/ijlpr.2023.13.3.P10-P16

Keywords:

PCOS, Overweight, Hirsutism, Anxiety, Lifestyle

Abstract

Polycystic ovary disorder is a fluctuated and regularly intricate cluster of metabolic and endocrine anomalies. This study aims to assess the risk of PCOS among women aged 15-45 years. This is an online-based cross-sectional survey conducted among women of childbearing age in South India. The data was collected online by providing google links to fill out questionnaire forms by various social media platforms. The questionnaire consists of demographic details and assessment questions. Microsoft Excel was used to interpret data. Statistical analysis done by using chi-square test. A total of 466 women responded, among which the women of 15-25 years and 25-36 years, h 32.46% have hirsutism,22.7% have infertility and overweight problems, 24.7% have mood swings, 49.2% have sleep disturbances, 55.5% have tiredness, 41.9% people have good awareness regarding exercise and lifestyle modifications. This study reveals that there is no proper knowledge about PCOS in the population, especially among girls and women, therefore there is a need to educate the public regarding PCOS at a younger age for better health outcomes. 

References

Szydlarska D, Machaj M, Jakimiuk A. History of discovery of polycystic ovary syndrome. AdvClinExp Med. 2017;26(3):555-8. doi: 10.17219/acem/61987, PMID 28791833.

Balaji S, Amadi C, Prasad S, BalaKasav J, Upadhyay V, Singh AK et al. Urban rural comparisons of polycystic ovary syndrome burden among adolescent girls in a hospital setting in India. BioMed Res Int. 2015;2015:158951. doi: 10.1155/2015/158951, PMID 25629036.

Gupta M, Melwani V, Priya A, Toppo M, Khan A, Sethia S. A study to assess the prevalence of polycystic ovarian disease among girls aged 15-21 years from selected SchoolsandCollegesinBhopalCity [internet]; 2021. Medical. Available from: adrpublications.in [cited Mar 23 2021]. Available from: https://medical.adrpublications.in/index.php/IndianJ-YouthandAdolescentHealth/article/view/1287.

Franik G, Krysta K, Madej P, Gimlewicz-Pięta B, Oślizło B, Trukawka J et al. Sleep disturbances in women with polycystic ovary syndrome. GynecolEndocrinol. 2016;32(12):1014-7. doi: 10.1080/09513590.2016.1196177. Madusudhanan RR, Nambisan B, Brahmanandan M, Radha S. Study on the prevalence and characteristics of metabolic syndrome in women of reproductive age group with polycystic ovarian syndrome. Journal of South Asian Federation of Obstetrics and Gynaecology. 2017;9(4):341-7. doi: 10.5005/jp-journals-10006-1526. Journal of South Asian Federation of Obstetrics and Gynaecology.2017;9(4):341-347.

VidyaBharathi R, Swetha S, Neerajaa J, VarshaMadhavica J, Janani DM, Rekha SN et al. An epidemiological survey: effect of predisposing factors for PCOS in Indian urban and rural population. Middle East FertilSoc J. 2017;22(4):313-6. doi: 10.1016/j.mefs.2017.05.007.

Francis R. A prospective study on the usage of metformin and awarness of lifestyle modification in polycystic ovary syndrome at various hospitals, Palakkad. World J Pharm Pharm Sci. 2017:1326-35.

9. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycystic ovaries. American Journal of Obstetrics and Gynecology. 1935;29(2):181-91. doi: 10.1016/S0002-9378(15)30642-6.

Hull MG. Epidemiology of infertility and polycystic ovarian disease: endocrinological and demographic studies. GynecolEndocrinol. 1987;1(3):235-45. doi: 10.3109/09513598709023610, PMID 3140583.

Jungheim ES, Lanzendorf SE, Odem RR, Moley KH, Chang AS, Ratts VS. Morbid obesity is associated with lower clinical pregnancy rates after in vitro fertilization in women with polycystic ovary syndrome. FertilSteril. 2009;92(1):256-61. doi: 10.1016/j.fertnstert.2008.04.063, PMID 18692801.

Palomba S, Russo T, Orio F, Falbo A, Manguso F, Sammartino A et al. Uterine effects of clomiphene citrate in women with polycystic ovary syndrome: a prospective controlled study. Hum Reprod. 2006;21(11):2823-9. doi: 10.1093/humrep/del267, PMID 16835214.

ZehraBehboodiMoghadam et al. conducted a study named Polycystic ovary syndrome and its impact on Iranian women’s quality of life: a population-based study (in bmc women’s health 2018 Oct 11). Which concluded that that decrease in the quality of life was associated with PCOS related conditions such as hirsutism, infertility and menstrual problems.

Hirsutism – Symptoms and causes [internet]. Mayo Clinic Publications; 2021 [cited Mar 3 2021]. Available from: https://www.mayoclinic.org/diseases-conditions/hirsutism/symptoms-causes/syc-20354935.

Desai NA D. S.S. Patel P. Prevalence of polycystic ovary syndrome and its associated risk factors among adolescent and young girls in Ahmedabad region. Indian Journal of Pharmacy Practice. R Tiwari T. 2018;11(3):119-25.

Chaudhari AP, Mazumdar K, Mehta PD. Anxiety, depression, and quality of life in women with polycystic ovarian syndrome. Indian J Psychol Med. 2018;40(3):239-46. doi: 10.4103/IJPSYM.IJPSYM_561_17, PMID 29875531.

PCOS and infertility – what it is, symptoms & treatment | CCRM fertility [internet]; 2021. CCRM Fertility [cited Mar 3 2021]. Available from: https://www.ccrmivf.com/pcos-infertility/.

Largo R. Obesity and PCOS: implications for diagnosis and treatment. SeminReprod Med. 2021;2012;30(06):4Fertility.

Health line: medical information and health advice you can trust [internet]; 2021. Healthline.com [cited Mar 3 2021]. Available from: https://www.healthline.com/.

Drosdzol A, Skrzypulec V, Plinta R. Quality of life, mental health and self-esteem in hirsute adolescent females. J PsychosomObstetGynaecol. 2010;31(3):168-75. doi: 10.3109/0167482X.2010.501398, PMID 20626242.

Katon W, Von Korff M, Lin E, Lipscomb P, Russo J, Wagner E et al. Distressed high utilizers of medical care. DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry. 1990;12(6):355-62. doi: 10.1016/0163-8343(90)90002-t, PMID 2245919.

Benson S, Hahn S, Tan S, Mann K, Janssen OE, Schedlowski M et al. Prevalence and implications of anxiety in polycystic ovary syndrome: results of an internet-based survey in Germany. Hum Reprod. 2009;24(6):1446-51. doi: 10.1093/humrep/dep031, PMID 19223290.

Laggari V, Diareme S, Christogiorgos S, Deligeoroglou E, Christopoulos P, Tsiantis J, et al. Anxiety and depression in adolescents with polycystic ovary syndrome and Mayer-Rokitansky-Kuster-Hauser syndrome. J PsychosomObstetGynaecol € ObstetGynaecol2009;30. 2009;30(2):83-8. doi: 10.1080/01674820802546204, PMID 19533486.

Published

2023-05-01

How to Cite

Ishrar, S. M. G. ., Narayana, G. ., Aneesa.K. S, A. ., Priya, C. ., & Swetha, R. (2023). Assessment of Risk Factors of Polycystic Ovarian Syndrome Among Women: An Online Based Survey: Pharmaceutical Science-Pharmacy practice. International Journal of Life Science and Pharma Research, 13(3), P10-P16. https://doi.org/10.22376/ijlpr.2023.13.3.P10-P16

Issue

Section

Research Articles